Crystal structures of the Mnk2 kinase domain reveal an inhibitory conformation and a zinc binding site

被引:62
作者
Jauch, R
Jäkel, S
Netter, C
Schreiter, K
Aicher, B
Jäckle, H
Wahl, MC
机构
[1] Max Planck Inst Biophys Chem, Abt Zellulare Biochem Rontgenkristallog, D-37077 Gottingen, Germany
[2] Max Planck Inst Biophys Chem, Abt Mol Entwicklungsbiol, D-37077 Gottingen, Germany
[3] DeveloGen AG, D-37097 Gottingen, Germany
关键词
D O I
10.1016/j.str.2005.07.013
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Human mitogen-activated protein kinases (MAPK)interacting kinases 1 and 2 (Mnk1 and Mnk2) target the translational machinery by phosphorylation of the eukaryotic initiation factor 4E (eIF4E). Here, we present the 2.1 angstrom crystal structure of a nonphosphorylated Mnk2 fragment that encompasses the kinase domain. The results show Mnk-specific features such as a zinc binding motif and an atypical open conformation of the activation segment. In addition, the ATP binding pocket contains an Asp-Phe-Asp (DFD) in place of the canonical magnesium binding Asp-Phe-Gly (DFG) motif. The phenylalanine of this motif sticks into the ATP binding pocket and blocks ATP binding as observed with inhibitor bound and, thus, inactive p38 kinase. Replacement of the DFD by the canonical DFG motif affects the conformation of Mnk2, but not ATP binding and kinase activity. The results suggest that the ATP binding pocket and the activation segment of Mnk2 require conformational switches to provide kinase activity.
引用
收藏
页码:1559 / 1568
页数:10
相关论文
共 39 条
  • [1] Kinetic and catalytic mechanisms of protein kinases
    Adams, JA
    [J]. CHEMICAL REVIEWS, 2001, 101 (08) : 2271 - 2290
  • [2] Drosophila Lk6 kinase controls phosphorylation of eukaryotic translation initiation factor 4E and promotes normal growth and development
    Arquier, N
    Bourouis, M
    Colombani, J
    Léopold, P
    [J]. CURRENT BIOLOGY, 2005, 15 (01) : 19 - 23
  • [3] THE CCP4 SUITE - PROGRAMS FOR PROTEIN CRYSTALLOGRAPHY
    BAILEY, S
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-BIOLOGICAL CRYSTALLOGRAPHY, 1994, 50 : 760 - 763
  • [4] Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
  • [5] Structural bioinformatics-based design of selective, irreversible kinase inhibitors
    Cohen, MS
    Zhang, C
    Shokat, KM
    Taunton, J
    [J]. SCIENCE, 2005, 308 (5726) : 1318 - 1321
  • [6] Towards complete validated models in the next generation of ARP/wARP
    Cohen, SX
    Morris, RJ
    Fernandez, FJ
    Ben Jelloul, M
    Kakaris, M
    Parthasarathy, V
    Lamzin, VS
    Kleywegt, GJ
    Perrakis, A
    [J]. ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY, 2004, 60 : 2222 - 2229
  • [7] A small molecule-kinase interaction map for clinical kinase inhibitors
    Fabian, MA
    Biggs, WH
    Treiber, DK
    Atteridge, CE
    Azimioara, MD
    Benedetti, MG
    Carter, TA
    Ciceri, P
    Edeen, PT
    Floyd, M
    Ford, JM
    Galvin, M
    Gerlach, JL
    Grotzfeld, RM
    Herrgard, S
    Insko, DE
    Insko, MA
    Lai, AG
    Lélias, JM
    Mehta, SA
    Milanov, ZV
    Velasco, AM
    Wodicka, LM
    Patel, HK
    Zarrinkar, PP
    Lockhart, DJ
    [J]. NATURE BIOTECHNOLOGY, 2005, 23 (03) : 329 - 336
  • [8] MNK1, a new MAP kinase-activated protein kinase, isolated by a novel expression screening method for identifying protein kinase substrates
    Fukunaga, R
    Hunter, T
    [J]. EMBO JOURNAL, 1997, 16 (08) : 1921 - 1933
  • [9] HANKS SK, 1991, METHOD ENZYMOL, V200, P38
  • [10] CRYSTAL-STRUCTURE OF THE TYROSINE KINASE DOMAIN OF THE HUMAN INSULIN-RECEPTOR
    HUBBARD, SR
    WEI, L
    ELIS, L
    HENDRICKSON, WA
    [J]. NATURE, 1994, 372 (6508) : 746 - 754